Williams Syndrome Medline Alert - June 1999

From the Medical Literature - June 1999


Record  1

The molecular basis of vascular disorders. Towbin JA; Casey B; Belmont J Baylor College of Medicine, Department of Pediatric Cardiology, One Baylor Plaza, Houston, Texas 77030, USA [email protected] Am J Hum Genet (UNITED STATES) Mar 1999, 64 (3) p678-84, ISSN 0002-9297 Languages: ENGLISH Document type: JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL (31 Refs.)


Record 2

Elastin mutation and cardiac disease. Chowdhury T; Reardon W Mothercare Unit of Clinical Genetics and Fetal Medicine, Institute of Child Health, 30, Guilford Street, London WC1N 1EH, United Kingdom. Pediatr Cardiol (UNITED STATES) Mar-Apr 1999, 20 (2) p103-7, ISSN 0172-0643 Languages: ENGLISH Document type: JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL

Characterization of the molecular basis of structural cardiac disease includes elucidating the pathogenesis of certain vascular disease by demonstrating mutations of the Elastin gene as the cause of familial supravalvular aortic stenosis (SVAS) and Williams' syndrome (WS). Defining the etiology of SVAS has clinical implications in terms of prenatal and presymptomatic diagnosis and possible earlier intervention with medical therapy. This review considers the evidence relating Elastin mutations to SVAS and WS and outlines the possible mechanisms by which these mutations give rise to cardiac disease. Finally, the implications which Elastin mutation identification has on current clinical practice and future research directions are considered. (28 Refs.)


This page hosted by Get your own Free Home Page
1
Hosted by www.Geocities.ws